Tropical
c. 1374 CE — Mali Empire, recorded by Ibn Khaldun
African trypanosomiasis, historically known as sleeping sickness, was a disease that devastated populations across sub-Saharan Africa for centuries before its causative agent was identified at the turn of the twentieth century. Colonial-era medical expeditions and laboratory investigations eventually revealed the parasitic and entomological basis of the condition, transforming it from a mysterious and widely feared affliction into a subject of intensive scientific investigation. The history of the disease is deeply intertwined with the history of colonial medicine, tropical public health, and early parasitology.
Historical Narrative
Written accounts of a severe wasting and somnolent illness among populations in sub-Saharan Africa appeared in the records of Arab travelers and traders as early as the fourteenth century. The Arab historian Ibn Khaldun, writing in the late fourteenth century, described the death of the Mali ruler Mansa Mari II from a condition characterized by overwhelming sleepiness, one of the earliest written accounts historians have associated with the disease. Coastal African kingdoms were also observed by Portuguese traders in the fifteenth and sixteenth centuries to suffer periodically from an epidemic somnolent illness that decimated both human populations and cattle herds, the latter of which European observers associated with a condition called nagana.
During the era of European exploration and trade, ship surgeons and missionaries produced accounts of a wasting illness among West and Central African populations marked by progressive lethargy, swollen lymph nodes in the neck — a clinical finding that British naval surgeon Thomas Winterbottom described in detail in 1803 and which later bore his name — and eventual neurological decline leading to death. Winterbottom's account, based on observations in Sierra Leone, represented one of the first systematic European medical descriptions of the condition and noted that enslaved traders reportedly refused to purchase individuals who displayed the characteristic neck swelling, recognizing it as a sign of fatal illness.
The scientific unraveling of African trypanosomiasis accelerated dramatically at the turn of the twentieth century. In 1902, Robert Michael Forde, a British physician working in the Gambia, observed unusual motile organisms in the blood of a steamboat captain suffering from a febrile illness. His colleague Joseph Everett Dutton identified these organisms as a previously unknown trypanosome, naming the species Trypanosoma brucei gambiense. Dutton's identification was a foundational moment in the history of tropical medicine and established the parasitic origin of the illness. Tragically, Dutton himself died of the disease in 1905 while conducting fieldwork in the Congo.
A major epidemic of sleeping sickness that swept through the Uganda Protectorate beginning around 1900 and ultimately killed hundreds of thousands of people galvanized British colonial medical authorities into action. The Royal Society dispatched a sleeping sickness commission to Uganda, and David Bruce, the Scottish microbiologist who had previously linked nagana in cattle to a trypanosome transmitted by tsetse flies, was a central figure in establishing the same transmission mechanism in the human disease. Bruce's prior work in the 1890s identifying the tsetse fly as the vector of animal trypanosomiasis made him a pivotal figure when investigators sought to explain the Uganda epidemic's spread.
In German East Africa, Robert Koch conducted extensive field investigations of sleeping sickness in the early twentieth century, experimenting with arsenical compounds as potential treatments, a line of research that reflected the broader use of heavy metal compounds in early chemotherapy. Paul Ehrlich's laboratory work on arsenical compounds during the same period, which yielded early therapeutic agents for trypanosomiasis as well as syphilis, established a new paradigm for chemotherapeutic approaches to infectious disease. The development of these early arsenical compounds, though extremely toxic and representing only a partial medical solution, marked the beginning of organized pharmacological efforts against the disease and shaped the trajectory of tropical medicine for decades.
Key Historical Figures
Historical narrative only — this page describes how African trypanosomiasis was understood historically. It is not medical advice and does not describe current diagnosis or treatment. Sourced from verified medical history references (NIH, Encyclopaedia Britannica, and standard medical history texts). See our medical disclaimer.